We are frequently confronted with a request to consider valve implantation in patients who will not live to see a clear overall improvement of their prognosis. The decision to withhold interventional treatment often does not come easily and should be made following ethically informed protocols and guidance.
We will review the various patient groups with reduced life expectancy, highlight the recommended decision pathways, refer to the available experience and guidelines, and discuss the management choices for this difficult cohort of patients.
Patient groups with limited life expectancy
Many patients presenting to the heart valve service ...
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Baseline severe MR, transthoracic echocardiography
November 20, 2020